• Microglial Nr4a1, C3, and TMJ-Linked Depression

  2026-09-09

  The reference study links temporomandibular joint inflammation to hippocampal microglial activation, excessive synaptic pruning, and depression-like behaviors through a Nr4a1–C3 mechanism. Its combination of inflammatory modeling, microglial suppression, targeted gene manipulation, and synaptic imaging provides a framework for testing how peripheral pain reshapes central emotional circuits.

• SB525334: TGF-beta1 Receptor Inhibitor Workflow

  2026-09-09

  Build cleaner TGF-beta pathway experiments with SB525334, from rapid Smad2/3 phosphorylation inhibition in cells to fibrosis and renal disease model validation. The workflow also explains how to interpret ALK5 blockade in diabetic wound studies without confusing pathway inhibition with therapeutic benefit.

• GI 254023X: ADAM10 Inhibitor Workflows

  2026-09-08

  GI 254023X combines nanomolar ADAM10 inhibition with strong ADAM17 selectivity, enabling cleaner studies of sheddase-dependent signaling and barrier injury. This practical guide connects target engagement to Jurkat, endothelial, and preclinical vascular assays while emphasizing dose control, orthogonal readouts, and troubleshooting.

• Verbascoside in Neuroimmune Signaling Research

  2026-09-07

  Verbascoside is a PKC/NF-κB inhibitor that offers a mechanistic way to test how inflammatory signaling may influence microglial synaptic pruning. This article translates findings from a TMJ inflammation study into rigorous assay concepts while distinguishing established evidence from promising cross-domain hypotheses.

• Annexin V-FITC/PI Apoptosis Assay Kit Guide

  2026-09-07

  The Annexin V-FITC/PI Apoptosis Assay Kit provides a practical two-marker workflow for separating viable, early apoptotic, and membrane-compromised cell populations. It is suitable for research flow cytometry or fluorescence microscopy, but the staining pattern should not be treated as a standalone diagnosis of apoptosis mechanism or therapeutic response.

• BRD4–RAC1 Co-targeting in Breast Cancer

  2026-09-05

  The reference study identifies combined BRD4 and RAC1 inhibition as a subtype-aware strategy that suppresses breast cancer growth, migration, stem-like properties, and tumorigenesis. Its mechanistic model connects JQ1 and NSC-23766 activity to disruption of the c-MYC–G9a–FTH1 axis and repression of HDAC1, providing a framework for studying epigenetic and Rac1-dependent cooperation.

• Luminescent ATP Detection Assay Kit for UC Research

  2026-09-04

  The Luminescent ATP Detection Assay Kit converts cellular energy status into a sensitive luminescent readout for ulcerative colitis models, including cultured cells and tissue lysates. Its mild lysis workflow supports complementary protein analyses, helping researchers connect ATP depletion with NOX2-driven oxidative stress, mitochondrial injury, and inflammation.

• Bone Transport, TGF-β1, and Diabetic Foot Repair

  2026-09-04

  A 2026 rat study identifies TGF-β1/TGFBR1 signaling as a mechanistic link between bone transport, angiogenesis, immune regulation, and diabetic foot ulcer repair. Its combination of surgical comparison, proteomics, molecular assays, and pathway inhibition provides a framework for testing how osteo-immune signals influence chronic wound healing.

• α-Linolenic Acid: Applied Research Workflows

  2026-09-03

  Build reproducible ALA experiments for lipid flux, cardiovascular signaling, inflammation, and cancer models. This guide combines practical dosing, solvent control, oxidation management, and a careful comparison with recent arachidonic acid immunology findings.

• NSP15 Inhibitor Screening: Thymopentin and Oleuropein

  2026-09-03

  The 2021 reference study combined structure-based virtual screening of a natural-product library with molecular-dynamics simulations to identify thymopentin and oleuropein as high-ranking SARS-CoV-2 NSP15 binders. Its results provide a computational starting point for antiviral research, but the predicted inhibition and biological effects require biochemical, cellular, and pharmacological validation.

• Meropenem A5124 for Reliable Cell Assays

  2026-09-02

  Learn how Meropenem (SKU A5124) can reduce bacterial confounding in viability, proliferation, cytotoxicity, and Gram-negative infection-model workflows. This scenario-driven guide covers mechanism, solvent compatibility, protocol controls, resistance interpretation, and practical product-selection criteria.

• MnTBAP Chloride: Mitochondrial Redox Workflows

  2026-09-02

  MnTBAP Chloride gives researchers a practical way to test whether mitochondrial superoxide contributes to cellular injury, inflammation, or stress-related phenotypes. This guide translates evidence from endothelial, inflammatory, and chronic-stress models into controlled workflows, assay choices, and troubleshooting steps.

• SB 431542 in Pulmonary Vascular Remodeling

  2026-09-01

  SB 431542 is a selective ALK5 inhibitor that helps researchers test how TGF-β signaling controls pulmonary artery smooth muscle cell behavior. This article translates vascular-remodeling evidence into a causality-focused assay strategy, with practical controls and interpretation limits.

• Tiamulin (Thiamutilin): Applied Research Guide

  2026-09-01

  Tiamulin combines ribosome-targeted antibacterial activity with a researchable anti-inflammatory profile, making it useful for pathogen susceptibility studies, veterinary infection models, and TNF-α signaling experiments. This guide translates product specifications and a classic susceptibility-testing study into practical workflows, controls, and troubleshooting decisions.

• (-)-Arctigenin for NF-κB–Macrophage EV Studies

  2026-08-31

  Use (-)-Arctigenin as a pathway-perturbation tool to separate inflammatory NF-κB signaling from macrophage extracellular-vesicle effects in breast cancer models. Its nanomolar iNOS and MEK1 activity supports dose-resolved workflows, while careful controls prevent pathway convergence from being mistaken for direct miR-660 targeting.

8556 records 1/571 page Next 12345 下5页 Last page